Investigational Treatment for hATTR Amyloidosis Shows Promising Results in Trials
According to a story from Rare Disease Report, the pharmaceutical company Alnylam Pharmaceuticals announced the results of Phase 3 trials for its experimental drug patisiran. The drug is in the…